FDA.reportPublic FDA data

NDC 26637-131-05 - Tiletamine-Zolazepam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
26637-131
Requested NDC
26637-131-05
Package NDCs from labels
26637-131-05
Manufacturer
Putney, Inc.
Effective date
2015-04-16
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Tiletamine-Zolazepam - Putney, Inc.Putney, Inc.2015-04-16PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
tiletamine hydrochlorideACTIVE INGREDIENT99TAQ2QWJITILETAMINE-ZOLAZEPAM (TILETAMINE HYDROCHLORIDE AND ZOLAZEPAM HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION [PUTNEY, INC.]1
zolazepam hydrochlorideACTIVE INGREDIENT45SJ093Q1NTILETAMINE-ZOLAZEPAM (TILETAMINE HYDROCHLORIDE AND ZOLAZEPAM HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION [PUTNEY, INC.]1
tiletamineACTIVE MOIETY2YFC543249TILETAMINE-ZOLAZEPAM (TILETAMINE HYDROCHLORIDE AND ZOLAZEPAM HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION [PUTNEY, INC.]1
zolazepamACTIVE MOIETYG1R474U58UTILETAMINE-ZOLAZEPAM (TILETAMINE HYDROCHLORIDE AND ZOLAZEPAM HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION [PUTNEY, INC.]1
mannitolINACTIVE INGREDIENT3OWL53L36ATILETAMINE-ZOLAZEPAM (TILETAMINE HYDROCHLORIDE AND ZOLAZEPAM HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION [PUTNEY, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MannitolMANNITOLHospira, Inc.8ad3145e-00e7-4412-b9a5-06f00f264f302026-04-21Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
QR PAINANALGESICMARYHELENE ENTERPRISES INC8f8f53e3-fe31-e7b5-e053-2995a90a710d2025-11-14WarningsExact identifier
unii: 3OWL53L36A
QR PAINANALGESICMARYHELENE ENTERPRISES INC9984a510-30be-4013-e053-2995a90a841e2025-11-14WarningsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLProPharma Distribution430669d7-9ad1-9a04-e063-6394a90ababb2025-11-07Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
Sorbitol-MannitolSORBITOL AND MANNITOLICU Medical Inc.5b44e248-4b7b-4777-954a-921c7b3099442025-10-30Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLICU Medical Inc.ba7bf864-8a4d-4262-8fd1-00174fa2f9d12025-10-24Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
OsmitrolMANNITOLBaxter Healthcare Company0d914965-7001-45cb-ba51-d7c5964b05bc2025-08-26Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLHenry Schein, Inc.e2444db1-9dfe-451f-a33c-9b00786464d22025-05-20Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MANNITOLMANNITOLHF Acquisition Co LLC, DBA HealthFirst999ce711-2d5b-0d7d-e053-2995a90a26892024-01-27Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLB. Braun Medical Inc.d12cc802-b538-4065-a264-f474ff3b30432023-08-15Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
MannitolMANNITOLFresenius Kabi USA, LLCc395e13d-6ea1-4104-8b37-669cfb982f042023-03-16Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.